Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[.]
S. Garg, P.W. Serruys.
Coronary stents: Current status.
J Am Coll Cardiol, 56 (2010), pp. S1-S42
[.]
J.A. Shand, V. Kodoth, I. Menown.
BA. Novel stent and drug elution technologies. Interv Cardiol, 3 (2011), pp. 473-481
[.]
B. Scheller, C. Hehrlein, W. Bocksch, W. Rutsch, D. Haghi, U. Dietz, et al.
Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
N Engl J Med, 355 (2006), pp. 2113-2124
[.]
B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Bohm, G. Nickenig.
Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.
Circulation, 110 (2004), pp. 810-814
[.]
B. Scheller, C. Hehrlein, W. Bocksch, W. Rutsch, D. Haghi, U. Dietz, et al.
Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxelcoated balloon catheter.
Clin Res Cardiol, 97 (2008), pp. 773-781
[.]
M. Unverdorben, C. Vallbracht, B. Cremers, H. Heuer, C. Hengstenberg, C. Maikowski, et al.
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.
Circulation, 119 (2009), pp. 2986-2994
[.]
P.R. Stella, A. Belkacemi, R. Waksman, S. Stahnke, R. Torguson, R.P. von Strandmann, et al.
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment.
Euro Intervention, 7 (2011), pp. 705-710
[.]
B. Vaquerizo, A. Serra, F. Miranda-Guardiola, V. Martínez, J. Antoni Gómez-Hospital, A. Iñiguez, et al.
One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry.
Interv Cardiol, 24 (2011), pp. 518-528
[.]
A. Latib, A. Colombo, F. Castriota, A. Micari, A. Cremonesi, F. De Felice, et al.
A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) Study.
J Am Coll Cardiol, 60 (2012), pp. 2473-2480
[0.]
J. Mieres, C. Fernández-Pereira, G. Risau, L. Solórzano, R. Pauletto, A.M. Rodríguez-Granillo, et al.
One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: Results from the DiabEtic Argentina Registry (DEAR).
Cardiovasc Revasc Med, 13 (2012), pp. 265-271
[1.]
A. Belkacemi, P. Agostoni, H.M. Nathoe, M. Voskuil, C. Shao, E. Van Belle, et al.
First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
J Am Coll Cardiol, 59 (2012), pp. 2327-2337
[2.]
J.C. Fanggiday, P.R. Stella, S.H. Guyomi, P.A. Doevendans.
Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
Catheter Cardiovasc Interv, 71 (2008), pp. 629-635
[3.]
Belkacemi A, Agostoni P, Voskuil M, Stella PR. Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study. Euro Intervention. 201; 7 (Suppl K): K66-9.
[4.]
D.G. Mathey, I. Wendig, M. Boxberger, K. Bonaventura, F.X. Kleber.
Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial.
Euro Intervention, 7 (2011), pp. K61-K65
[5.]
M. Krokidis, S. Spiliopoulos, K. Katsanos, T. Sabharwal.
Peripheral applications of drug-coated balloons: past, present and future.
Cardiovasc Intervent Radiol, (2012),
Copyright © 2013. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular